Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)

Recruiting now

Conditions studied: Human Papillomavirus

In brief

To learn if new HPV tests can provide the same results as standard HPV tests. The findings from this study may aid in the development of new HPV tests that require less equipment and are more accessible.

Key facts

Study ID

NCT06434337

Run by

M.D. Anderson Cancer Center

People needed

600

Starts

2024-07-23

Expected to finish

2028-03-31

Last updated by the study team

2026-05-18

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• People with a cervix 21 years of age or older.
• Scheduled to undergo hrHPV testing at MD Anderson and The Harris Health System (LBJ Hospital) according to national and institutional guidelines at time of enrollment OR are anticipated to undergo a LEEP, ECC, or biopsy.
• Willing and able to provide informed consent.
• Able to perform protocol-required activities. Able to speak and read English or Spanish.

You may not qualify if…

• Patient or provider decision not to perform HPV testing. This does not apply to patients that are undergoing either a LEEP, ECC or biopsy.
• Participant or provider decision not to collect a sample for this study.
• Participants that are pregnant.

Where it is running

• MD Anderson Cancer Center — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.